Finance

Lists
Why is 002082 down 4.72%?
Dive Deeper
002082:SHE
Wanbangde Pharmaceuticl Hldng Grp Co Ltd
CNÂ¥11.51
-4.72%
(-0.57) 1D
Oct 16, 3:04:51 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002082...
Open
CNÂ¥12.23
High
CNÂ¥12.50
Low
CNÂ¥11.50
Mkt. cap
7.93B
Avg. vol.
14.37M
Volume
11.77M
52-wk high
CNÂ¥36.24
52-wk low
CNÂ¥8.53
EPS
-CNÂ¥0.19
Shares outstanding
611.69M
No. of employees
1K
Open
CNÂ¥12.23
High
CNÂ¥12.50
Low
CNÂ¥11.50
Mkt. cap
7.93B
Avg. vol.
14.37M
Volume
11.77M
52-wk high
CNÂ¥36.24
52-wk low
CNÂ¥8.53
EPS
-CNÂ¥0.19
Shares outstanding
611.69M
No. of employees
1K
News stories
From web sources and news partners
About Wanbangde Pharmaceuticl Hldng Grp Co Ltd
CEO-
Employees1.35K
Founded1985
Headquarters-
SectorPharmaceutical industry
Websitechinawepon.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
439.15M
99.62M
374.21M
214.60M
Cost of goods sold
296.93M
48.06M
161.35M
166.88M
Cost of revenue
296.93M
48.06M
161.35M
166.88M
Research and development expenses
18.12M
9.90M
11.47M
13.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
112.01M
91.52M
80.55M
63.97M
Operating expense
145.02M
166.87M
69.10M
102.28M
Total operating expenses
441.96M
214.93M
230.45M
269.16M
Operating income
-2.80M
-115.31M
143.76M
-54.56M
Other non operating income
2.27M
-1.48M
-874.44K
-7.73M
EBT including unusual items
-9.16M
-159.75M
129.35M
-59.70M
EBT excluding unusual items
-11.11M
-117.95M
132.21M
-64.00M
Income tax expense
-1.66M
13.43M
28.69M
-16.15M
Effective tax rate
18.11%
-8.41%
22.18%
27.04%
Other operating expenses
4.87M
2.30M
3.07M
5.42M
Net income
-9.00M
-171.70M
102.95M
-39.67M
Net profit margin
-2.05%
-172.36%
27.51%
-18.49%
Earnings per share
-
-
-
-
Interest and investment income
-
11.79M
-
7.88M
Interest expense
-9.61M
-14.74M
-10.68M
-8.46M
Net interest expenses
-9.61M
-2.96M
-10.68M
-578.77K
Depreciation and amortization charges
-
-
-
-
EBITDA
21.11M
-90.04M
169.04M
-23.06M
Gain or loss from assets sale
297.90K
-600.48K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps